GENEVA, July 6 -- AUTOTELIC BIO INC. filed a patent application (KR2025/018927) for “PHARMACEUTICAL COMPOSITION FOR TREATING FIBROSIS COMPRISING SGLT-2 INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER”. With publication no. WO/2026/141971, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/351
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....